Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy

  • Barbara A. Murphy
  • , Robert J. Motzer
  • , Madhu Mazumdar
  • , Vaia Vlamis
  • , Jerome Nisselbaum
  • , Dean Bajorin
  • , George J. Bosl

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences

Immunology and Microbiology